BP2A.F DOMINARI HOLDINGS DL-01

Financial Services Biotechnology Frankfurt Exchange
0.6790 EUR
Close of Nov 11, 2026
0.6790 3.57
Market cap
EUR 16.2M
P/E
-
P/B
1.08x
ROE
-352.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is BP2A.F undervalued?

Graham number

The Graham number of DOMINARI HOLDINGS DL-01 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

DOMINARI HOLDINGS DL-01 fundamental analysis

No fundamental analysis for DOMINARI HOLDINGS DL-01 yet.

DOMINARI HOLDINGS DL-01 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About DOMINARI HOLDINGS DL-01

Dominari Holdings Inc., through its subsidiaries, engages in wealth management, investment banking, sales and trading, asset management, and insurance activities in the United States. The company offers full-service brokerage services, including exchange-traded and over-the-counter corporate equity and debt securities, money market instruments, exchange-traded options, municipal bonds, mutual funds, exchange-traded funds, and unit investment trusts; and financial and wealth …

Full company profile